Sichenzia Ross Ference Carmel LLP Represents 60 Degrees Pharmaceuticals in $2.4 Million Public Offering

Press Release – New York, NY – January 30th, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) in its initial public offering of $2.4 Million.

The offering consists of 5,260,901 units (the “Units) at a price to the public of $0.385 per Unit and 999,076 pre-funded units (the “Pre-Funded Units”) at a price to the public of $0.375 per Pre-Funded Unit.

Each Unit consists of one share of common stock and one warrant exercisable for one share of common stock (the “Warrant”). Each Warrant will have an exercise price of $0.4235 per share, be exercisable immediately upon issuance, and expire five years from the date of issuance. Each Pre-Funded Unit consists of one pre-funded warrant exercisable for one share of common stock (the “Pre-Funded Warrant”) and one Warrant identical to the Warrants included in the Units.

60 Degrees Pharmaceuticals, Inc., founded in 2010, specializes in the development and marketing of new medicines for the prevention and treatment of tropical infectious diseases, including those considered neglected by the World Health Organization. In 2018, their lead product ARAKODA, designed to prevent malaria, was approved for use by the US Food and Drug Administration.

WallachBeth Capital LLC is the Sole Bookrunner for the offering.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel, Phil Magri, and counsel Jeffrey Hua.

Click here for a full list of recent transactions headed by SRFC.

This memorandum is provided by Sichenzia Ross Ference Carmel LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

• Author
• Recent Posts

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry.  In addition to handling routine to complex commercial matters, SRFC’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.  The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation.  Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies.  The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA).  These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct.  Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records.  The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRFC's LinkedIn page

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

• Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $8.5 Million Offering - September 13, 2024
• Sichenzia Ross Ference Carmel LLP Represents NuZee, Inc. in Two PIPE Transactions Totaling $4.3 Million - September 12, 2024